A randomized, single dose, two treatment, two period, crossover bioequivalence study of cefixime (as trihydrate) suspension in healthy participants comparing Acacime® suspension produced by ACAI / Iraq to Suprax® suspension produced by Hikma / Jordan. (2018). Al Mustansiriyah Journal of Pharmaceutical Sciences, 17(1), 7. https://doi.org/10.32947/ajps.v17i1.72